Last 12 months
Inside the activity.
5 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2021 Filed Mar 26, 2021 20:45 UTC |
Hart Jayne B.Chief People Officer
|
GrantCommon Stock | 13,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001519749-21-000002 · edgardoc.xml · nonDerivative · entry 1 Hart Jayne B. · CIK 0001519749 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,128 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:41 UTC |
Jackson BenjaminE.V.P., General Counsel
|
GrantCommon Stock | 18,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001779964-21-000002 · edgardoc.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,029 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:37 UTC |
Parkinson PaulEVP Strategy and Innovation
|
GrantCommon Stock | 10,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001826133-21-000004 · edgardoc.xml · nonDerivative · entry 1 Parkinson Paul · CIK 0001826133 · EVP Strategy and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,407 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:33 UTC |
Haas Kevin RichardChief Technology Officer
|
GrantCommon Stock | 13,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001843872-21-000009 · edgardoc.xml · nonDerivative · entry 1 Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,769 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
GrantCommon Stock | 19,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001219036-21-000004 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,922 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:23 UTC |
Verratti MarkPresident, Myriad Neuroscience
|
GrantCommon Stock | 15,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001517026-21-000002 · edgardoc.xml · nonDerivative · entry 1 Verratti Mark · CIK 0001517026 · President, Myriad Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,130 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:19 UTC |
Lambert NicolePresident, Myriad Oncology,
|
GrantCommon Stock | 29,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001770252-21-000002 · edgardoc.xml · nonDerivative · entry 1 Lambert Nicole · CIK 0001770252 · President, Myriad Oncology, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,768 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:15 UTC |
Riggsbee Richard BryanChief Financial Officer
|
GrantCommon Stock | 32,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-21-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,925 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:46 UTC |
Riggsbee Richard BryanChief Financial Officer
|
Disposition to issuerCommon Stock | 11,175 | $29.69 | $331,785.75 |
DisclosureSEC source: 0001621899-21-000002 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,151 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:43 UTC |
Ancona MargaretSVP Enterprise Transformation
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001843568-21-000006 · edgardoc.xml · nonDerivative · entry 1 Ancona Margaret · CIK 0001843568 · SVP Enterprise Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2022, 25% on February 18, 2023, 25% on February 18, 2024, and 25% on February 18, 2025. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:38 UTC |
Haas Kevin RichardSVP Technology
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001843872-21-000006 · edgardoc.xml · nonDerivative · entry 1 Haas Kevin Richard · CIK 0001843872 · SVP Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,443 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2022, 25% on February 18, 2023, 25% on February 18, 2024, and 25% on February 18, 2025. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 74,445 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · derivative · entry 6 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,445 shares Expires 2021-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · derivative · entry 5 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,555 shares Expires 2021-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
SaleCommon Stock | 5,555 | $29.71 | $165,056.27 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · nonDerivative · entry 4 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,575 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,555 | $18.00 | $99,990.00 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · nonDerivative · entry 3 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
SaleCommon Stock | 74,445 | $29.71 | $2,211,991.73 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · nonDerivative · entry 2 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,575 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:10 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionCommon Stock | 74,445 | $18.00 | $1,340,010.00 |
DisclosureSEC source: 0001219036-21-000002 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 21:40 UTC |
Parkinson PaulEVP Strategy and Innovation
|
SaleCommon Stock | 11,824 | $25.00 | $295,600.00 |
DisclosureSEC source: 0001826133-21-000002 · edgardoc.xml · nonDerivative · entry 1 Parkinson Paul · CIK 0001826133 · EVP Strategy and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,746 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:44 UTC |
Reitan Colleen FDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032908 · doc4.xml · nonDerivative · entry 1 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,576 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:41 UTC |
Skovronsky DanielDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032906 · doc4.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,930 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 22:27 UTC |
SPIEGELMAN DANIEL KDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001238403-20-000007 · edgardoc.xml · nonDerivative · entry 1 SPIEGELMAN DANIEL K · CIK 0001238403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,451 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 22:24 UTC |
Newcomer Lee NisleyDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001788981-20-000003 · edgardoc.xml · nonDerivative · entry 1 Newcomer Lee Nisley · CIK 0001788981 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,576 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 22:14 UTC |
LANGER DENNISDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001274225-20-000002 · edgardoc.xml · nonDerivative · entry 1 LANGER DENNIS · CIK 0001274225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,679 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 22:09 UTC |
Phanstiel S. LouiseDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001471518-20-000004 · edgardoc.xml · nonDerivative · entry 1 Phanstiel S. Louise · CIK 0001471518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,679 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 22:11 UTC |
DREISMANN HEINRICHDirector
|
GrantCommon Stock | 15,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001379372-20-000002 · edgardoc.xml · nonDerivative · entry 1 DREISMANN HEINRICH · CIK 0001471714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,679 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 13:57 UTC |
Phanstiel S. LouiseDirector
|
PurchaseCommon Stock | 15,000 | $16.62 | $249,336.00 |
DisclosureSEC source: 0001471518-20-000002 · edgardoc.xml · nonDerivative · entry 1 Phanstiel S. Louise · CIK 0001471518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,790 Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 02:22 UTC |
Parkinson PaulEVP Strategy and Innovation
|
Disposition to issuerCommon Stock | 2,218 | $12.43 | $27,569.74 |
DisclosureSEC source: 0001826133-20-000009 · edgardoc.xml · nonDerivative · entry 1 Parkinson Paul · CIK 0001826133 · EVP Strategy and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,570 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:19 UTC |
Parkinson PaulEVP Strategy and Innovation
|
GrantCommon Stock | 21,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001826133-20-000007 · edgardoc.xml · nonDerivative · entry 1 Parkinson Paul · CIK 0001826133 · EVP Strategy and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,788 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:21 UTC |
Hart Jayne B.Executive VP Human Resources
|
GrantCommon Stock | 17,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001519749-20-000011 · edgardoc.xml · nonDerivative · entry 1 Hart Jayne B. · CIK 0001519749 · Executive VP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,802 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:17 UTC |
Jackson BenjaminE.V.P., General Counsel
|
GrantCommon Stock | 29,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001779964-20-000008 · edgardoc.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,150 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:14 UTC |
Lambert NicolePresident, MGL
|
GrantCommon Stock | 44,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001770252-20-000010 · edgardoc.xml · nonDerivative · entry 1 Lambert Nicole · CIK 0001770252 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,212 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:11 UTC |
Verratti MarkPresident Assurex Health Inc.
|
GrantCommon Stock | 31,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001517026-20-000008 · edgardoc.xml · nonDerivative · entry 1 Verratti Mark · CIK 0001517026 · President Assurex Health Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,689 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:06 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
GrantCommon Stock | 39,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001219036-20-000008 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,575 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 12:02 UTC |
Riggsbee Richard BryanChief Financial Officer
|
GrantCommon Stock | 44,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-20-000012 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,326 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:43 UTC |
Hart Jayne B.Executive VP Human Resources
|
Disposition to issuerCommon Stock | 2,218 | $13.04 | $28,922.72 |
DisclosureSEC source: 0001519749-20-000009 · edgardoc.xml · nonDerivative · entry 1 Hart Jayne B. · CIK 0001519749 · Executive VP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,949 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:40 UTC |
Jackson BenjaminE.V.P., General Counsel
|
Disposition to issuerCommon Stock | 416 | $13.04 | $5,424.64 |
DisclosureSEC source: 0001779964-20-000006 · edgardoc.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,366 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:38 UTC |
Lambert NicolePresident, MGL
|
Disposition to issuerCommon Stock | 591 | $13.04 | $7,706.64 |
DisclosureSEC source: 0001770252-20-000008 · edgardoc.xml · nonDerivative · entry 1 Lambert Nicole · CIK 0001770252 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,001 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:35 UTC |
Verratti MarkPresident Assurex Health Inc.
|
Disposition to issuerCommon Stock | 725 | $13.04 | $9,454.00 |
DisclosureSEC source: 0001517026-20-000006 · edgardoc.xml · nonDerivative · entry 1 Verratti Mark · CIK 0001517026 · President Assurex Health Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,431 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:32 UTC |
Ford AlexanderChief Operating Officer
|
Disposition to issuerCommon Stock | 6,653 | $13.04 | $86,755.12 |
DisclosureSEC source: 0001644335-20-000010 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,040 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:30 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Disposition to issuerCommon Stock | 5,544 | $13.04 | $72,293.76 |
DisclosureSEC source: 0001219036-20-000006 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,379 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:27 UTC |
Riggsbee Richard BryanChief Financial Officer
|
Disposition to issuerCommon Stock | 6,653 | $13.04 | $86,755.12 |
DisclosureSEC source: 0001621899-20-000010 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,372 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 17:15 UTC |
Hart Jayne B.Executive VP Human Resources
|
Disposition to issuerCommon Stock | 2,218 | $12.44 | $27,591.92 |
DisclosureSEC source: 0001519749-20-000007 · edgardoc.xml · nonDerivative · entry 3 Hart Jayne B. · CIK 0001519749 · Executive VP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,167 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 17:06 UTC |
Jackson BenjaminE.V.P., General Counsel
|
Disposition to issuerCommon Stock | 2,935 | $12.44 | $36,511.40 |
DisclosureSEC source: 0001779964-20-000004 · edgardoc.xml · nonDerivative · entry 3 Jackson Benjamin · CIK 0001779964 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,782 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 17:10 UTC |
Parkinson PaulEVP Strategy and Innovation
|
Disposition to issuerCommon Stock | 3,327 | $12.44 | $41,387.88 |
DisclosureSEC source: 0001826133-20-000005 · edgardoc.xml · nonDerivative · entry 3 Parkinson Paul · CIK 0001826133 · EVP Strategy and Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,058 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:59 UTC |
Lambert NicolePresident, MGL
|
Disposition to issuerCommon Stock | 2,935 | $12.44 | $36,511.40 |
DisclosureSEC source: 0001770252-20-000006 · edgardoc.xml · nonDerivative · entry 4 Lambert Nicole · CIK 0001770252 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,592 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:55 UTC |
Verratti MarkPresident Assurex Health Inc.
|
Disposition to issuerCommon Stock | 2,376 | $12.44 | $29,557.44 |
DisclosureSEC source: 0001517026-20-000004 · edgardoc.xml · nonDerivative · entry 4 Verratti Mark · CIK 0001517026 · President Assurex Health Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,156 F3 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:47 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Disposition to issuerCommon Stock | 3,627 | $12.44 | $45,119.88 |
DisclosureSEC source: 0001219036-20-000004 · edgardoc.xml · nonDerivative · entry 4 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,923 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:52 UTC |
Ford AlexanderChief Operating Officer
|
Disposition to issuerCommon Stock | 4,546 | $12.44 | $56,552.24 |
DisclosureSEC source: 0001644335-20-000008 · edgardoc.xml · nonDerivative · entry 4 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,693 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:42 UTC |
Riggsbee Richard BryanChief Financial Officer
|
Disposition to issuerCommon Stock | 4,546 | $12.44 | $56,552.24 |
DisclosureSEC source: 0001621899-20-000008 · edgardoc.xml · nonDerivative · entry 4 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,025 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 17:15 UTC |
Hart Jayne B.Executive VP Human Resources
|
Disposition to issuerCommon Stock | 1,664 | $12.44 | $20,700.16 |
DisclosureSEC source: 0001519749-20-000007 · edgardoc.xml · nonDerivative · entry 2 Hart Jayne B. · CIK 0001519749 · Executive VP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,385 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.